Table 1 Patient characteristics stratified by AKI status
Non-AKI (N = 952) | AKI (n = 508) | All (N = 1460) | |
|---|---|---|---|
Age (years) | 50.9 (20.3) | 58 (18) | 53.4 (19.8) |
Female | 405 (42.5%) | 210 (41.3%) | 615 (42.1%) |
Reimbursement | |||
Government officer | 56 (5.9%) | 31 (6.1%) | 85 (5.8%) |
Out-of-pockets | 810 (85.2%) | 417 (82.1%) | 1227 (84.1%) |
SS, private insurances | 85 (8.9%) | 60 (11.8%) | 145 (9.9%) |
BMI | |||
Underweight | 79 (8.3%) | 36 (7.1%) | 115 (7.9%) |
Normal | 707 (74.3%) | 358 (70.5%) | 1065 (73.0%) |
Overweight/obese | 166 (17.4%) | 114 (22.4%) | 280 (19.1%) |
Primary diagnosis | |||
Cardiovascular diseases | 60 (6.3%) | 48 (9.5%) | 108 (7.4%) |
Renal diseases | 16 (1.7%) | 49 (9.7%) | 65 (4.5%) |
Infectious diseases | 157 (16.5%) | 77 (15.2%) | 234 (16.0%) |
Gastrointestinal diseases | 113 (11.9%) | 58 (11.4%) | 171 (11.7%) |
Hematologic disease | 13 (1.4%) | 9 (1.8%) | 22 (1.5%) |
Respiratory diseases | 101 (10.6%) | 81 (15.9%) | 182 (12.5%) |
Neurologic diseases | 150 (15.8%) | 51 (10.0%) | 201 (13.8%) |
Endocrine diseases | 34 (3.6%) | 42 (8.3%) | 76 (5.2%) |
Rheumatologic diseases | 2 (0.2%) | 1 (0.2%) | 3 (0.2%) |
Oncologic diseases | 8 (0.8%) | 9 (1.8%) | 17 (1.2%) |
Surgical-related diseases | 298 (31.3%) | 83 (16.3%) | 381 (26.1%) |
Comorbidity | |||
HT | 260 (27.3%) | 179 (35.2%) | 439 (30.1%) |
DM | 168 (17.6%) | 160 (31.5%) | 328 (22.5%) |
CKD | 25 (2.6%) | 121 (23.8%) | 146 (10%) |
Cerebrovascular | 23 (2.4%) | 18 (3.5%) | 41 (2.8%) |
Malignancy | 21 (2.2%) | 15 (3%) | 36 (2.5%) |
CAD | 11 (1.2%) | 14 (2.8%) | 25 (1.7%) |
APACHE II score | 15.6 (8.5) | 18.3 (8.5%) | 16.6 (8.6%) |
Non-renal SOFA score | 5.4 (3.2) | 5.5 (3.5) | 5.4 (3.3) |
Vasopressors | 201 (21.1%) | 153 (30.1%) | 354 (24.3%) |
Mechanical ventilation | 260 (27.3%) | 98 (19.3%) | 358 (24.5%) |
Urine output (mL/day) | 1293.7 (872.1) | 747.2 (731.5) | 1103.6 (865.7) |
Anemiaa | 315 (33.1%) | 273 (53.7%) | 588 (40.3%) |
Percent of fluid accumulationb | 0.42 (1.5) | 0.79 (1.5) | 0.55 (1.6) |
Diuretics | 99 (10.4%) | 110 (21.7%) | 209 (14.3%) |